A carregar...
Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma.
We have previously developed a daunorubicin resistant subline of Ehrlich ascites carcinoma (EA/DR) for studies on the reversal of daunorubicin resistance. The mean survival of untreated BALB/c mice bearing drug sensitive parental tumour (EA/DS) is 18.4 +/- 0.6 days, mice bearing EA/DS treated with f...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
1986
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2001522/ https://ncbi.nlm.nih.gov/pubmed/3741759 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|